Select Page

Multi-cohort analysis identifies a blood-based immune transcriptomic signature for early lung cancer detection
“Early diagnosis of lung cancer is critical for timely intervention and reducing mortality. The immune system and cancer are intricately linked, which provides a unique opportunity to monitor changes in the immune system as a biomarker of cancer development.”

Special Discussion on Lung Cancer in Young Adults – LUNGevity Foundation
“”This World Lung Cancer Day, join us for a Facebook Live to discuss lung cancer in young adults and how biology translates to clinical practice. LUNGevity’s Upal Basu Roy co-hosts this exciting event with Lung Cancer Iniative’s Jenni Danai with guests Jaclyn LoPiccolo (Dana-Farber Cancer Institute) and patient advocate Gwen Orilio.”

Lung Cancer Study Links Treatment History to Quality-of-Life Differences
“Key Takeaways: A holistic, value-based care approach is essential for enhancing quality of life in non-small cell lung cancer patients, focusing on treatment side effects and patient preferences. Treatment history significantly influences health-related quality of life, with nonmetastatic patients reporting more sleep disturbances and metastatic patients experiencing better physical and social functioning.”

Nadunolimab Combo Exhibits Early Efficacy in Advanced NSCLC
“Nadunolimab (CAN04), when used with platinum-based chemotherapy, exhibited promising early efficacy outcomes in a small cohort of patients with advanced non–small cell lung cancer (NSCLC), according to results from the phase 2a CANFOUR trial (NCT03267316) published in Lung Cancer.”

A little dopamine could go a long way in treating lung cancer
“Small cell lung cancer (SCLC), one of the deadliest types of lung cancer, is an aggressive tumor that metastasizes early compared to other cancers and can quickly develop resistance to chemotherapy  —  making it extremely difficult to treat.  However, at The Hormel Institute, University of Minnesota, scientists in the lab of Associate Professor Dr. Luke Hoeppner are working to change this  —  and one of the solutions might have something to do with activating dopamine receptors.”